MEHTA VIREN purchased 29171.5% of their position (250K shares) of TRAWS PHARMA, INC. on the open market
Open‑market purchase worth $50.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/27/2019ACC: 0001179110-19-012105
+500K
Net shares
Net buyer
$50.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
500K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+250K
Price / share
$0.20
Trade value
$50K
% of position
29171.5%
11/25/2019
857.00→250.86K
Total
Net shares
+250K
Net value
$50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/25/2019 | P · Purchase | +250K | $0.20 | $50K | 29171.5% | 857.00 | 250.86K |
| Total | +250K | $50K | ||||||
Derivative Transactions1
Warrant (right to purchase)
Direct
Converts to
Common Stock
250K shares
Shares
+250K
Strike price
.2
Held after
250K
Exercisable
—
11/25/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant (right to purchase) Direct | Common Stock250K shares | 11/25/2019 | P · Purchase | +250K | .2 | — | 250K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned56.00
Common Stock
IndirectShares owned54.00
Total
110.00 indirect110.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 56.00 | Indirect |
| Common Stock | 54.00 | Indirect |
| Total | 110.00 | 110.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported